made intravenously. The heparin is reverse at the end of the embolization. On the technical point of view, there is no difference with Histoacryl except the color of the mixture. We always mixed Glubran with Lipiodol" (Guerbet, Aulnay s/s bois, France). The concentration is adapted to the nidus type angio architecture (the size of the nidus and the flow of the shunt). Commonly, we use a concentration between 25 and 50%. We think that experience is very important and that the neuroradiologist must master different concentrations of glue and the different kind of behaviour of the microcatheter 2 .
Even if we try to control the flow during the injection, the situation of the tip of the microcatheter also influence the concentration of glue. For bAVM, most of the time we use a flow-dependant catheter (1,2 to 1,5 Fr). We try to navigate without guide wire to reach the nidus , and when it is possible in a wedge position. Before injecting the glue, we do a biplane superselective angiography in the "working projection". The working projection is chosen to allow visual control of the nidus penetration and arterial reflux when the glubran will be deposited. Then we flush the microcatheter with glucose and we inject the glue with a 3cc syringe during a biplane run. The quantity of glue depends of the size of the nidus (0,7 to 2cc), at the end of the injection the operator must aspi-New agents of liquid acrylic glue for embolization of brain vascular malformation have made their appearance in the therapeutic arsenal. Among those, we have change using previously Histoacryl" (Braun, Aesculap AG, Tuttingen, Germany) to choose Glubran" (GEM Srl, Viareggio, Italy) in 2003. Since this date, we have used Glubran for around 150 embolizations mostly in bAVM, dural arteriovenous shunt, direct fistulae and exceptionally aneurysms. The fact that Glubran bears the CE trademark with specific indication for neuroradiological endovascular use is very important on the legal point of view even if Histoacryl has been used worldwide by the most experience teams in cerebral vascular malformation endovascular field treatment 3 . To our experience, and in agreement with experimental works, Glubran does not produce bubbles and seems to diffuse more homogeneously and in a more predictable way than Histoacryl 1 .
The principle of intra nidal embolization with cyanoacrylate remains exactly the same and Glubran does not change the concept of treatment. It requires extensive experience which was acquired with Histoacryl and easily translates with Glubran.
All patients are treated under general anaesthesia, a 5 french guiding catheter is used to catheterize the main feeding trunk (flush with saline) and a bolus of 1000 UI of heparin is During the navigation, the operator must be very cautious when using guidewire to prevent any perforation. We preferred not to push the The arterial reflux during the glue injection must be mastered to prevent any normal brain artery occlusion.
During the withdrawing, we have not had catheter rupture while using Glubran nor gluing the microcatheter in place.
Conclusion
The concept of intranidal embolization for bAVM has not changed since we use Glubran. We have not modified our injection technique. 
